Author:
Holden Inge K.,Lillebaek Troels,Seersholm Niels,Andersen Peter H.,Wejse Christian,Johansen Isik S.
Abstract
Abstract
Monitoring of tuberculosis (TB) treatment outcome is essential to ensure an effective TB control program. In this nationwide retrospective cohort study from Denmark we present TB treatment outcome rates and risk factors associated with an unfavourable outcome. All patients notified with pulmonary TB from 2009 through 2014 were included. Logistic regression analyses were used to identify risk factors for unfavourable outcome. In total, 1681 pulmonary TB cases were included. TB treatment success rates increased during the study period. In 2014, the treatment success rate reached 85% for new culture positive cases whereas 7% cases interrupted treatment. The mortality decreased during the study period from 12.3% to 4.1%. Several risk factors associated with unfavourable outcome were identified in a multivariable model: male (OR: 2.56), Greenlandic origin (OR: 1.80), abuse of alcohol (OR: 2.90), history of mental disorder (OR: 2.46), and anaemia at time of treatment initiation (OR: 1.92). In a TB low incidence setting such as the Danish, it is important to maintain focus on preventing an unfavourable TB outcome. Patient management and treatment can be optimized by taking into consideration risk factors such as those identified in the present study.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Pablos-Mendez, A., Knirsch, C. A., Barr, R. G., Lerner, B. H. & Frieden, T. R. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med 102, 164–170 (1997).
2. Bradford, W. Z. et al. The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA. Lancet 348, 928–931,
https://doi.org/10.1016/S0140-6736(96)03027-9
(1996).
3. Cegielski, J. P. et al. Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America,
https://doi.org/10.1093/cid/ciu572
(2014).
4. Statens Serum Institut. Tuberkulosebehandling 2008–2010,
www.ssi.dk/aktuelt/nyhedsbreve/epi-nyt/2013/Uge27-2013
. (Date last updated 2013. Date last accesed: Jan 1 2019).
5. WHO Regional Office for Europe/European Centre for Disease Prevention and Control. Tuberculosis surveillance and monitoring in Europe 2019–2017 data. Copenhagen: WHO Regional Office for Europe; (2019).
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献